FDAFDA · Food and drugs·Recall number D-0939-2023
Famotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark Therapeutics Inc., USA, Mahwah, NJ 07430, Made in India, NDC 72657-113-20.
Published July 26, 2023 · Recall initiated: May 1, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.
What to do
Voluntary: Firm initiated
Recall details
- Brand
- FAMOTIDINE
- Manufacturer
- Glenmark Therapeutics, Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0372657132015
- Lot
- FA2022001B, Exp 03/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.